PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner

Ishida, Tatsuhiro, Wang, XinYu, Shimizu, Taro, Nawata, Kosuke, Kiwada, Hiroshi·2007·Journal of Controlled Release
DOI 10.1016/j.jconrel.2007.05.015

Cited by (382)

Items 101–200 of 382

  1. Immunological Risk of Injectable Drug Delivery Systems
    Wim Jiskoot, Rianne MF van Schie, Myrra G. Carstens, Huub Schellekens · 2009 · Pharmaceutical Research
  2. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics
    Muthunarayanan Muthiah, In‐Kyu Park, Chong‐Su Cho · 2013 · Expert Opinion on Drug Delivery
  3. Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response
    Taro Shimizu, Masako Ichihara, Yasuo Yoshioka, Tatsuhiro Ishida, Shinsaku Nakagawa, Hiroshi Kiwada · 2012 · Biological and Pharmaceutical Bulletin
  4. Liposomal corticosteroids for the treatment of inflammatory disorders and cancer
    Burcin Ozbakir, Bart J. Crielaard, Josbert M. Metselaar, Gert Storm, Twan Lammers · 2014 · Journal of Controlled Release
  5. Modified curcumin with hyaluronic acid: Combination of pro-drug and nano-micelle strategy to address the curcumin challenge
    Jinglei Li, Gye Hwa Shin, Xiguang Chen, Hyun Jin Park · 2015 · Food Research International
  6. Poly(2-ethyl-2-oxazoline)-PLA-g-PEI amphiphilic triblock micelles for co-delivery of minicircle DNA and chemotherapeutics
    Gaspar, Vítor M., Gonçalves, Cristine, de Melo-Diogo, Duarte, Costa, Elisabete C., Queiroz, João A., Pichon, Chantal, Sousa, Fani, Correia, Ilídio J. · 2014 · Journal of Controlled Release
  7. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes
    Taro Shimizu, Amr Selim Abu Lila, Risako Fujita, Mizuki Awata, Munehira Kawanishi, Yosuke Hashimoto, Keiichiro Okuhira, Yu Ishima, Tatsuhiro Ishida · 2018 · European Journal of Pharmaceutics and Biopharmaceutics
  8. Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice
    Sherif E. Emam, Nehal E. Elsadek, Amr Selim Abu Lila, Haruka Takata, Yoshino Kawaguchi, Taro Shimizu, Hidenori Ando, Yu Ishima, Tatsuhiro Ishida · 2021 · Journal of Controlled Release
  9. Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles
    Dan Peer · 2012 · Advanced Drug Delivery Reviews
  10. Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis
    Rebecca Anderson, Àngels Franch, Margarida Castell, Francisco José Pérez-Cano, Rolf Bräuer, Dirk Pohlers, Mieczyslaw R. Gajda, Alexandros Siskos, Θεοδώρα Κάτσιλα, Constantin Tamvakopoulos et al. · 2010 · Arthritis Research & Therapy
  11. Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance
    Shiraishi, Kouichi, Kawano, Kumi, Maitani, Yoshie, Aoshi, Taiki, Ishii, Ken J., Sanada, Yusuke, Mochizuki, Shinichi, Sakurai, Kazuo, Yokoyama, Masayuki · 2016 · Journal of Controlled Release
  12. Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
    Taro Shimizu, Yu Mima, Yosuke Hashimoto, Masami Ukawa, Hidenori Ando, Hiroshi Kiwada, Tatsuhiro Ishida · 2015 · Immunobiology
  13. A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse
    Morgan D. McSweeney, Timothy Wessler, Lauren Price, Elizabeth C. Ciociola, Leah B. Herity, Joseph A. Piscitelli, William C. Zamboni, M. Gregory Forest, Yanguang Cao, Samuel K. Lai · 2018 · Journal of Controlled Release
  14. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon
    Taro Shimizu, Tatsuhiro Ishida, Hiroshi Kiwada · 2012 · Immunobiology
  15. Materials design at the interface of nanoparticles and innate immunity
    Gregory Lee Szeto, Erin Lavik · 2016 · Journal of Materials Chemistry B
  16. Environmental Immunology: Lessons Learned from Exposure to a Select Panel of Immunotoxicants
    Joanna M. Kreitinger, Celine A. Beamer, David M. Shepherd · 2016 · The Journal of Immunology
  17. The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol)
    Jonathan K. Armstrong · 2009 · Birkhäuser Basel eBooks
  18. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production
    Tatsuaki Tagami, Kazuya Nakamura, Taro Shimizu, Tatsuhiro Ishida, Hiroshi Kiwada · 2009 · Journal of Controlled Release
  19. Microbial L-asparaginase as a Potential Therapeutic Agent for the Treatment of Acute Lymphoblastic Leukemia: The Pros and Cons
    Noura El‐Ahmady El‐Naggar, Sara M. El-Ewasy, Nancy M. El-Shweihy · 2014 · International Journal of Pharmacology
  20. Polyethylene glycol in spinal cord injury repair: a critical review
    Xi Lu, T. Hiran Perera, Alexander B Aria, Laura A. Smith Callahan · 2018 · Journal of Experimental Pharmacology
  21. Red Blood Cells-Derived Vesicles for Delivery of Lipophilic Drug Camptothecin
    Sahil Malhotra, Shweta Dumoga, Parul Sirohi, Neetu Singh · 2019 · ACS Applied Materials & Interfaces
  22. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach
    Nicola d’Avanzo, Christian Celia, Antonella Barone, Maria Carafa, Luisa Di Marzio, Hélder A. Santos, Massimo Fresta · 2020 · Advanced Therapeutics
  23. Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles
    Yihui Deng, Zhao, Wang, Yan Yan, Ma, Zang, She · 2012 · International Journal of Nanomedicine
  24. Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids
    Fred Lühder, Holger Michael Reichardt · 2017 · International Journal of Molecular Sciences
  25. CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes
    Tatsuaki Tagami, Kazuya Nakamura, Taro Shimizu, Naoshi Yamazaki, Tatsuhiro Ishida, Hiroshi Kiwada · 2009 · Journal of Controlled Release
  26. Nanomedicine for the prevention, treatment and imaging of atherosclerosis
    Costas T. Psarros, Regent Lee, Marios Margaritis, Charalambos A. Antoniades · 2012 · Nanomedicine Nanotechnology Biology and Medicine
  27. Unintended effects of drug carriers: Big issues of small particles
    Hamideh Parhiz, Makan Khoshnejad, Jacob W. Myerson, Elizabeth D. Hood, Priyal Patel, Jacob Samuel Brenner, Vladimir R. Muzykantov · 2018 · Advanced Drug Delivery Reviews
  28. Ternary Protein Adsorption onto Brushes: Strong versus Weak
    Avraham Halperin, Martin Kröger · 2009 · Langmuir
  29. When carbon nanotubes encounter the immune system: Desirable and undesirable effects
    Hélène Dumortier · 2013 · Advanced Drug Delivery Reviews
  30. Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies
    Helena Freire Haddad, Jacqueline A. Burke, Evan Alexander Scott, Guillermo Antonio Ameer · 2021 · Regenerative Engineering and Translational Medicine
  31. Nanotechnology for the Detection and Therapy of Stroke
    Stuart Kyle, Sikha Saha · 2014 · Advanced Healthcare Materials
  32. Engineered cell-degradable poly(2-alkyl-2-oxazoline) hydrogel for epicardial placement of mesenchymal stem cells for myocardial repair
    Yaqi You, Kazuya Kobayashi, Burcu Colak, Piaopiao Luo, Edward J. Cozens, Laura Fields, Ken Suzuki, Julien E. Gautrot · 2020 · Biomaterials
  33. Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin
    Takuya Suzuki, Masako Ichihara, Kenji Hyodo, Eiichi Yamamoto, Tatsuhiro Ishida, Hiroshi Kiwada, Hiroshi Kikuchi, Hiroshi Ishihara · 2014 · International Journal of Pharmaceutics
  34. Current and emerging applications of saccharide-modified chitosan: a critical review
    Hamed Kazemi Shariat Panahi, Mona Dehhaghi, Hamid Amiri, Gilles J. Guillemin, Vijai Kumar Gupta, Ahmad Rajaei, Yadong Yang, Wanxi Peng, Junting Pan, Mortaza Aghbashlo et al. · 2023 · Biotechnology Advances
  35. Long circulating micelles of an amphiphilic random copolymer bearing cell outer membrane phosphorylcholine zwitterions
    Jing Zhao, Yu-Dong Chai, Jing Zhang, Pengfei Huang, Kenichi Nakashima, Yong‐Kuan Gong · 2015 · Acta Biomaterialia
  36. Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting
    Rahul Rattan, Somnath Bhattacharjee, Hong Zong, Corban Swain, Muneeb A. Siddiqui, Scott Visovatti, Yogendra M. Kanthi, Sajani Desai, David J. Pinsky, Sascha N. Goonewardena · 2017 · Bioorganic & Medicinal Chemistry
  37. A frustrating problem: Accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats
    Yongxue Zhao, Chunling Wang, Long Wang, Qiang Yang, Wenya Tang, Zhennan She, Yihui Deng · 2012 · European Journal of Pharmaceutics and Biopharmaceutics
  38. Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?
    Akbar Hasanzadeh, Michael Richard Hamblin, Jafar Kiani, Hamid Noori, Joseph Michael Hardie, Mahdi Karimi, Hadi Shafiee · 2022 · Nano Today
  39. Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer–methotrexate conjugate as a potential anticancer agent
    Yuehua Zhang, Thommey P. Thomas, Kyung-Hoon Lee, Minghsin Li, Hong Zong, Ankur M. Desai, Alina Kotlyar, Baohua Huang, Mark M. Banaszak Holl, James R. Baker · 2011 · Bioorganic & Medicinal Chemistry
  40. Liposomal Chemotherapeutics
    Emanuela Gentile, Felisa Cilurzo, Luisa Di Marzio, Maria Carafa, Cinzia Anna Ventura, Joy Wolfram, Donatella Paolino, Christian Celia · 2013 · Future Oncology
  41. Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance
    Jiaxuan Xia, Chen Chen, Meichen Dong, Ying Zhu, Anni Wang, Shiyi Li, Ru Zhang, Chunbo Feng, Xinnan Jiang, Xinchun Xu et al. · 2023 · Journal of Controlled Release
  42. Nanomedicine: is It Lost in translation?
    Khaled F. Greish, Aanchal Mathur, Moiz Bakhiet, Sébastien Taurin · 2018 · Therapeutic Delivery
  43. Accelerated blood clearance and hypersensitivity by PEGylated liposomes containing TLR agonists
    Camilla Stavnsbjerg, Esben Christensen, Rasmus Münter, Jonas R. Henriksen, Matthias Fach, Ladan Parhamifar, Camilla Laulund Christensen, Andreas Kjær, Anders E. Hansen, Thomas Lars Andresen · 2021 · Journal of Controlled Release
  44. A decade of innovation: Synthesis, properties and applications of PLA copolymers
    Zoi N. Terzopoulou, Alexandra Zamboulis, Nikolaos D. Bikiaris, Eleftheria Xanthopoulou, Rafail O. Ioannidis, Dimitrios Ν. Bikiaris · 2025 · Progress in Polymer Science
  45. Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs
    Yihui Deng, Chunling Wang, Xiaobo Cheng, Yuqing Su, Ying Pei, Yanzhi Song, Jiao Jiao, Zhenjun Huang, Yanfei Ma, Yinming Dong et al. · 2015 · International Journal of Nanomedicine
  46. Intracellular Delivery of Polymeric Nanocarriers: a Matter of size, shape, charge, Elasticity and Surface Composition
    Rachit Agarwal, Krishnendu Roy · 2013 · Therapeutic Delivery
  47. Fatty acids as therapeutic auxiliaries for oral and parenteral formulations
    Michael Hackett, Jennica L. Zaro, Wei‐Chiang Shen, Patrick C. Guley, Moo J. Cho · 2012 · Advanced Drug Delivery Reviews
  48. Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity
    Yu Mima, Amr Selim Abu Lila, Taro Shimizu, Masami Ukawa, Hidenori Ando, Yasuko Kurata, Tatsuhiro Ishida · 2017 · Journal of Controlled Release
  49. Preparation of PEG-grafted chitosan/streptokinase nanoparticles to improve biological half-life and reduce immunogenicity of the enzyme
    Hadi Baharifar, Mehdi Khoobi, Sepideh Arbabi Bidgoli, Amir Amani · 2019 · International Journal of Biological Macromolecules
  50. Long Circulating liposomes: Challenges and Opportunities
    Suyash Deodhar, Alekha K. Dash · 2018 · Therapeutic Delivery
  51. Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers
    Livia Palmerston Mendes, Can Sarısözen, Ed Luther, Jiayi Pan, Vladimir P. Torchilin · 2019 · Drug Delivery
  52. Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines
    Zui Zhang, Yuxiu Chu, Cheng Li, Wenjing Tang, Jun Qian, Xiaoli Wei, Weiyue Lu, Tianlei Ying, Changyou Zhan · 2020 · Journal of Controlled Release
  53. Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats
    Yanling Ma, Qiang Yang, Long Wang, Xinyu Zhou, Yongxue Zhao, Yihui Deng · 2011 · European Journal of Pharmaceutical Sciences
  54. Liposomes with cyclic RGD peptide motif triggers acute immune response in mice
    Wang, Xiaoyi, Wang, Huan, Jiang, Kuan, Zhang, Yanyu, Zhan, Changyou, Ying, Man, Zhang, Mingfei, Lu, Linwei, Wang, Ruifeng, Wang, Songli et al. · 2019 · Journal of Controlled Release
  55. Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment
    Jian Gao, Jiannan Li, Zengyou Luo, Hongyong Wang, Zhiming Ma · 2024 · Drug Design Development and Therapy
  56. A daunting task: manipulating leukocyte function with RNA i
    Dan Peer · 2013 · Immunological Reviews
  57. Functional coating of liposomes using a folate–polymer conjugate to target folate receptors
    Yoshie Maitani, Kaneko, Watanabe †↑ · 2012 · International Journal of Nanomedicine
  58. Effect of protein immunogenicity and PEG size and branching on the anti-PEG immune response to PEGylated proteins
    Xue Wan, Juankun Zhang, Weili Yu, Lijuan Shen, Shaoyang Ji, Tao Hu · 2016 · Process Biochemistry
  59. Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker
    Robin Q.H. Kloos, Inge Margriet van der Sluis, Enrico Mastrobattista, Wim E. Hennink, Rob Pieters, Jan‐Jaap Verhoef · 2019 · British Journal of Haematology
  60. Biophysical, biopharmaceutical and toxicological significance of biomedical nanoparticles
    Sangeetha Aula, Samyuktha Lakkireddy, Kaiser Jamil, Atya Kapley, A. V. N. Swamy, Lakkireddy Harivardhan Reddy · 2015 · RSC Advances
  61. Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles
    Hiroyuki Koide, Tomohiro Asai, Hiroki Kato, Hidenori Ando, Kouichi Shiraishi, Masayuki Yokoyama, Naoto Oku · 2012 · International Journal of Pharmaceutics
  62. Innate and adaptive immune responses toward nanomedicines
    Iara Maíra de Oliveira Viana, Sabrina Roussel, Joan Defrêne, Eliana Martins Lima, Frédéric Barabé, Nicolas Bertrand · 2021 · Acta Pharmaceutica Sinica B
  63. Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy
    Yihui Deng, Peng Yang, Ma, Zhao, She, Wang, Xiang Li, Wang · 2013 · International Journal of Nanomedicine
  64. Radionanomedicine: Widened perspectives of molecular theragnosis
    Dong Soo Lee, Hyung‐Jun Im, Yun‐Sang Lee · 2015 · Nanomedicine Nanotechnology Biology and Medicine
  65. Pharmacokinetic change of nanoparticulate formulation “Lactosome” on multiple administrations
    Eri Hara, A. Makino, Kensuke Kurihara, Fumihiko Yamamoto, Eiichi Ozeki, Shunsaku Kimura · 2012 · International Immunopharmacology
  66. Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives
    Sherif A. Gaballa, Taro Shimizu, Hidenori Ando, Haruka Takata, Sherif E. Emam, Eslam Ramadan, Youssef Wahib Naguib, Fatma Mohammed Mady, Khaled A. Khaled, Tatsuhiro Ishida · 2023 · Journal of Pharmaceutical Sciences
  67. Dual-Function, Cationic, Peptide-Coated Nanodiamond Systems: Facilitating Nuclear-Targeting Delivery for Enhanced Gene Therapy Applications
    Hoi Man Leung, Miu Shan Chan, Ling Sum Liu, Sze Wing Wong, Tsz Wan Lo, Cia‐Hin Lau, Chung Tin, Pik Kwan Lo · 2018 · ACS Sustainable Chemistry & Engineering
  68. Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon
    Marwa Mohamed El Sayed, Haruka Takata, Taro Shimizu, Yoshino Kawaguchi, Amr Selim Abu Lila, Nehal E. Elsadek, Eman Alaaeldin, Yu Ishima, Hidenori Ando, Amal Kamal et al. · 2020 · Journal of Controlled Release
  69. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints
    Mahendra Rai, Shital Bonde, Alka Yadav, Yulia Victorovna Plekhanova, Anatoly Nikolaevich Reshetilov, Indarchand R. Gupta, Patrycja Golińska, Raksha Pandit, Avinash P. Ingle · 2020 · Expert Review of Anti-infective Therapy
  70. Nanomedicine for prostate cancer using nanoemulsion: A review
    Aravindsiva Sasikumar, Kaladhar Kamalasanan · 2017 · Journal of Controlled Release
  71. Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes
    Xiaoyi Wang, Nana Meng, Songli Wang, Yanyu Zhang, Linwei Lu, Ruifeng Wang, Huitong Ruan, Kuan Jiang, Huan Wang, Danni Ran et al. · 2019 · Journal of Controlled Release
  72. Hemoglobin Vesicles, Polyethylene Glycol (PEG)ylated Liposomes Developed as a Red Blood Cell Substitute, Do Not Induce the Accelerated Blood Clearance Phenomenon in Mice
    Kazuaki Taguchi, Yukino Urata, Makoto Anraku, Hiroshi Watanabe, Daisuke Kadowaki, Hiromi Sakai, Hirohisa Horinouchi, Koichi Kobayashi, Eishun Tsuchida, Toru Maruyama et al. · 2009 · Drug Metabolism and Disposition
  73. Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
    Alaeddin Khalil, Gudrun Würthwein, Jana Golitsch, Georg Hempel, Manfred Fobker, Joachim Gerß, Anja Möricke, Martin Zimmermann, Petr Smíšek, Massimo Zucchetti et al. · 2020 · Haematologica
  74. Recent progress on polySarcosine as an alternative to PEGylation: Synthesis and biomedical applications
    Mohamed Fawzi Kabil, Hassan Mohamed El-Said Azzazy, Maha Nasr · 2024 · International Journal of Pharmaceutics
  75. Nanomedicine in cardiovascular therapy: recent advancements
    Ziyad M. Binsalamah, Arghya Paul, Satya Prakash, Dominique Shum‐Tim · 2012 · Expert Review of Cardiovascular Therapy
  76. Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles
    Lina Zhou, Sunitha Kodidela, Sandip Godse, Stacey M. Thomas-Gooch, Asit Kumar, Babatunde Raji, Kaining Zhi, Harry Kochat, Santosh Kumar · 2022 · Pharmaceuticals
  77. More than a delivery system: the evolving role of lipid-based nanoparticles
    Senjuti Karmaker, Plinio D. Rosales, Barath Tirumuruhan, Amartya Viravalli, Natalie Boehnke · 2025 · Nanoscale
  78. Application of Polyglycerol Coating to Plasmid DNA Lipoplex for the Evasion of the Accelerated Blood Clearance Phenomenon in Nucleic Acid Delivery
    Amr Selim Abu Lila, Yumi Uehara, Tatsuhiro Ishida, Hiroshi Kiwada · 2013 · Journal of Pharmaceutical Sciences
  79. Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice
    Morgan D. McSweeney, Limei Shen, Alexander C. DeWalle, Jordan B. Joiner, Elizabeth C. Ciociola, Dharmendra Raghuwanshi, Matthew Scott Macauley, Samuel K. Lai · 2020 · Journal of Controlled Release
  80. Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution
    Rasmus Münter, Esben Christensen, Thomas L. Andresen, Jannik B. Larsen · 2023 · Molecular Therapy — Methods & Clinical Development
  81. Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies
    Dag Sehlin, Marie Hedlund, Anna Lord, Hillevi Englund, Pär Gellerfors, Staffan Paulie, Lars Lannfelt, Frida Ekholm Pettersson · 2010 · Neurodegenerative Diseases
  82. Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route
    Haruka Takata, Taro Shimizu, Rina Yamade, Nehal E. Elsadek, Sherif E. Emam, Hidenori Ando, Yu Ishima, Tatsuhiro Ishida · 2023 · Journal of Controlled Release
  83. Understanding gold nanoparticles and their attributes in ovarian cancer therapy
    Rishabh Aggarwal, Afsana Sheikh, Masheera Akhtar, Mohammed Ghazwani, Umme Hani, Amirhossein Sahebkar, Prashant Kesharwani · 2025 · Molecular Cancer
  84. Polyethylene glycol: Properties, applications, and challenges
    Sherif A. Gaballa, Youssef Wahib Naguib, Fatma Mohammed Mady, Khaled Khaled · 2023 · Journal of advanced Biomedical and Pharmaceutical Sciences
  85. Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines
    Min Jae Yang, Zengyu Zhang, Pengpeng Jin, Kuan Jiang, Yifei Xu, Feng Pan, Kaisong Tian, Zhou Yuan, X. Liu, Jiaru Fu et al. · 2023 · International Journal of Pharmaceutics
  86. Design and Synthesis of Cationic Drug Carriers Based on Hyperbranched Poly(amine-ester)s
    Yan Pang, Qi Zhu, Jinyao Liu, Jieli Wu, Ruibin Wang, Suyun Chen, Xinyuan Zhu, Deyue Yan, Wei Huang, Bangshang Zhu · 2010 · Biomacromolecules
  87. Nanomedicine for the prevention, treatment and imaging of atherosclerosis
    Costas T. Psarros, Regent Lee, Marios Margaritis, Charalambos A. Antoniades · 2012 · Maturitas
  88. T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics
    Ruoxuan Sun, Mark G. Qian, Xiaobin Zhang · 2024 · mAbs
  89. Differential immunotoxicities of poly(ethylene glycol)- vs. poly(carboxybetaine)-coated nanoparticles
    Mahmoud Elsabahy, Ang Li, Fuwu Zhang, Deborah H. Sultan, Yongjian Liu, Karen L. Wooley · 2013 · Journal of Controlled Release
  90. Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: Promise for clinical application
    Ai Nagao, Amr Selim Abu Lila, Tatsuhiro Ishida, Hiroshi Kiwada · 2012 · International Journal of Pharmaceutics
  91. Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase
    JingXia Cui, Chunlei Li, Caixia Wang, Yanhui Li, Lan Zhang, Li Zhang, Haiyan Yang · 2008 · Journal of Pharmacy and Pharmacology
  92. The mechanisms of anti-PEG immune response are different in the spleen and the lymph nodes
    Philippe Grenier, Valérie Chénard, Nicolas Bertrand · 2022 · Journal of Controlled Release
  93. Identification of Polyethylene Glycol-Resistant Macrophages on Stealth Imaging in Vitro Using Fluorescent Organosilica Nanoparticles
    Michihiro Nakamura, Koichiro Hayashi, Mutsuki Nakano, Takafumi Kanadani, Kazue Miyamoto, Toshinari Kori, Kazuki Horikawa · 2015 · ACS Nano
  94. A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes
    Taro Shimizu, Amr Selim Abu Lila, Yoshino Kawaguchi, Yuna Shimazaki, Yuki Sumazaki Watanabe, Yu Mima, Yosuke Hashimoto, Keiichiro Okuhira, Gert Storm, Yu Ishima et al. · 2018 · The Journal of Immunology
  95. Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM
    Fengling Wang, Xi Ye, Yifan Wu, Huihui Wang, Chengming Sheng, Daiyin Peng, Weidong Chen · 2018 · Journal of Pharmaceutical Sciences
  96. Glycans in Nanomedicine, Impact and Perspectives
    Susanna Sampaolesi, Francesco Nicotra, Laura Russo · 2018 · Future Medicinal Chemistry
  97. Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood
    Jiahe Li, Charles C. Sharkey, Dantong Huang, Michael R. King · 2015 · Cellular and Molecular Bioengineering
  98. Hyperbranched Poly(2-oxazoline)s and Poly(ethylene glycol): A Structure–Activity Comparison of Biodistribution
    James Humphries, David Pizzi, Stefan Sonderegger, Nicholas L. Fletcher, Zachary H. Houston, Craig A. Bell, Kristian Kempe, Kristofer J. Thurecht · 2020 · Biomacromolecules
  99. An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes
    Bart J. Crielaard, Afrouz Yousefi, Joris P. Schillemans, Charlotte Vermehren, Kevin Buyens, Kevin Braeckmans, Twan Lammers, Gert Storm · 2011 · Journal of Controlled Release
  100. Biological Evaluation of Liposome-Encapsulated Hemoglobin Surface-Modified With a Novel PEGylated Nonphospholipid Amphiphile
    Vivek Ramshankar Yadav, Okhil Kumar Nag, Vibhudutta Awasthi · 2014 · Artificial Organs